Role of HDAC6 and Its Selective Inhibitors in Gastrointestinal Cancer
Worldwide, cancer is the second leading cause of mortality after cardiovascular diseases. Among the numerous malignant tumors in human, digestive system cancers are the primary cause of morbidity and mortality. Acetylation and deacetylation are crucially involved in cancer occurrence and development...
Guardado en:
Autores principales: | , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4bba92dba64941db88bd778c548d3f1b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:4bba92dba64941db88bd778c548d3f1b |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:4bba92dba64941db88bd778c548d3f1b2021-12-02T11:39:19ZRole of HDAC6 and Its Selective Inhibitors in Gastrointestinal Cancer2296-634X10.3389/fcell.2021.719390https://doaj.org/article/4bba92dba64941db88bd778c548d3f1b2021-12-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fcell.2021.719390/fullhttps://doaj.org/toc/2296-634XWorldwide, cancer is the second leading cause of mortality after cardiovascular diseases. Among the numerous malignant tumors in human, digestive system cancers are the primary cause of morbidity and mortality. Acetylation and deacetylation are crucially involved in cancer occurrence and development; in addition, the deacetylation process is regulated by histone deacetylases (HDACs). Among the 18 human HDACs that have been reported, HDAC6 has been widely studied. There is upregulated HDAC6 expression in numerous types of tumor tissues and is closely associated with clinicopathological characteristics. Moreover, several HDAC6 inhibitors have been identified; furthermore, there has been extensive research on their ability to inhibit the growth of many tumors. This review summarizes the roles of HDAC6 in different primary digestive system malignancies.Bingyi ZhouBingyi ZhouDeliang LiuDeliang LiuYuyong TanYuyong TanFrontiers Media S.A.articlehistone deacetylaseshistone deacetylase inhibitorgastrointestinal cancerdeacetylationubiquitinationBiology (General)QH301-705.5ENFrontiers in Cell and Developmental Biology, Vol 9 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
histone deacetylases histone deacetylase inhibitor gastrointestinal cancer deacetylation ubiquitination Biology (General) QH301-705.5 |
spellingShingle |
histone deacetylases histone deacetylase inhibitor gastrointestinal cancer deacetylation ubiquitination Biology (General) QH301-705.5 Bingyi Zhou Bingyi Zhou Deliang Liu Deliang Liu Yuyong Tan Yuyong Tan Role of HDAC6 and Its Selective Inhibitors in Gastrointestinal Cancer |
description |
Worldwide, cancer is the second leading cause of mortality after cardiovascular diseases. Among the numerous malignant tumors in human, digestive system cancers are the primary cause of morbidity and mortality. Acetylation and deacetylation are crucially involved in cancer occurrence and development; in addition, the deacetylation process is regulated by histone deacetylases (HDACs). Among the 18 human HDACs that have been reported, HDAC6 has been widely studied. There is upregulated HDAC6 expression in numerous types of tumor tissues and is closely associated with clinicopathological characteristics. Moreover, several HDAC6 inhibitors have been identified; furthermore, there has been extensive research on their ability to inhibit the growth of many tumors. This review summarizes the roles of HDAC6 in different primary digestive system malignancies. |
format |
article |
author |
Bingyi Zhou Bingyi Zhou Deliang Liu Deliang Liu Yuyong Tan Yuyong Tan |
author_facet |
Bingyi Zhou Bingyi Zhou Deliang Liu Deliang Liu Yuyong Tan Yuyong Tan |
author_sort |
Bingyi Zhou |
title |
Role of HDAC6 and Its Selective Inhibitors in Gastrointestinal Cancer |
title_short |
Role of HDAC6 and Its Selective Inhibitors in Gastrointestinal Cancer |
title_full |
Role of HDAC6 and Its Selective Inhibitors in Gastrointestinal Cancer |
title_fullStr |
Role of HDAC6 and Its Selective Inhibitors in Gastrointestinal Cancer |
title_full_unstemmed |
Role of HDAC6 and Its Selective Inhibitors in Gastrointestinal Cancer |
title_sort |
role of hdac6 and its selective inhibitors in gastrointestinal cancer |
publisher |
Frontiers Media S.A. |
publishDate |
2021 |
url |
https://doaj.org/article/4bba92dba64941db88bd778c548d3f1b |
work_keys_str_mv |
AT bingyizhou roleofhdac6anditsselectiveinhibitorsingastrointestinalcancer AT bingyizhou roleofhdac6anditsselectiveinhibitorsingastrointestinalcancer AT deliangliu roleofhdac6anditsselectiveinhibitorsingastrointestinalcancer AT deliangliu roleofhdac6anditsselectiveinhibitorsingastrointestinalcancer AT yuyongtan roleofhdac6anditsselectiveinhibitorsingastrointestinalcancer AT yuyongtan roleofhdac6anditsselectiveinhibitorsingastrointestinalcancer |
_version_ |
1718395699472629760 |